Turku, Finland

Timo Petteri Piironen

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timo Petteri Piironen. Retrieved from https://idiyas.com/inventor/timo-petteri-piironen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Timo Petteri Piironen: Innovator in Prostate Cancer Detection

Introduction

Timo Petteri Piironen is a notable inventor based in Turku, Finland. He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. His innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Timo Petteri Piironen holds a patent for "Prostate specific antigen peptides and uses thereof." This invention relates to peptides that can be utilized in the detection of free and complexed Prostate Specific Antigen, aiding in the diagnosis of prostate cancer. His work in this area is crucial for advancing medical technology and improving patient outcomes.

Career Highlights

Piironen is associated with Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in medical diagnostics.

Collaborations

Some of Timo Petteri Piironen's notable coworkers include Barry Lee Dowell and Hans Lilja. Their combined expertise has fostered an environment of innovation and collaboration, leading to advancements in prostate cancer detection technologies.

Conclusion

Timo Petteri Piironen's contributions to the field of medical diagnostics, particularly in prostate cancer detection, highlight the importance of innovation in healthcare. His work continues to pave the way for improved diagnostic methods and better patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…